Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07425015 · ClinicalTrials.gov registry record · NA
Ambulatory Long Length URodynamics Evaluation
A NA study of Benign Prostatic Hyperplasia and Urinary Bladder, Overactive, sponsored by Bright Uro.
- Recruiting
- Registry status
- NA
- Development phase
- 101
- Enrollment target
- 7
- Study locations
NCT07425015: Recruiting NA study of Benign Prostatic Hyperplasia and Urinary Bladder, Overactive, sponsored by Bright Uro.
NCT07425015 is a NA study of Benign Prostatic Hyperplasia and Urinary Bladder, Overactive that is actively recruiting participants, run by Bright Uro. The registered enrollment target is 101 participants, below the 549-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (82% lower). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07425015, a NA study of Benign Prostatic Hyperplasia and Urinary Bladder, Overactive, is actively recruiting participants, sponsored by Bright Uro.
- RECRUITING
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
- 7
- Study locations
Study Summary
A prospective, open-label, single arm interventional trial evaluating the safety and performance of the in-clinic and extended monitoring of the lower urinary tract using the Glean Urodynamics System.
Primary Outcome
Percentage of participants experiencing a qualifying adverse event attributable to the Glean Urodynamics System
Conditions Studied
Interventions
- DEVICE Glean Urodynamics System
Study Locations (7)
Maryland
- Chesapeake Urology Associates - Hanover
- Chesapeake Urology Associates - Owings Mills
Missouri
- Urology of St. Louis - St Louis
Ohio
- MetroHealth - Cleveland
South Carolina
- Southern Urogynecology Wellness & Aesthetics - West Columbia
South Dakota
- Sanford Health - Sioux Falls
Texas
- Urology Partner of North Texas - Arlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2026-02 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT07425015 shows while recruiting
NCT07425015 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 549-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (82% lower).
The record links to 7 conditions, with Benign Prostatic Hyperplasia appearing as the primary indexed condition, and to 1 intervention - of which Glean Urodynamics System is the first listed.
NCT07425015 lists 7 locations in 6 states (Maryland, Missouri, Ohio).
Frequently Asked Questions
What is clinical trial NCT07425015 about?
NCT07425015 is a clinical study titled "Ambulatory Long Length URodynamics Evaluation". A prospective, open-label, single arm interventional trial evaluating the safety and performance of the in-clinic and extended monitoring of the lower urinary tract using the Glean Urodynamics System.
What is the current status of trial NCT07425015?
This trial is currently recruiting. It is a NA study. The enrollment target is 101 participants. The study started on 2026-02. Estimated completion is 2027-06.
What conditions does trial NCT07425015 study?
This clinical trial studies the following conditions: Benign Prostatic Hyperplasia, Urinary Bladder, Overactive, Urology, Urodynamics, Urinary Incontinence (UI).
What interventions are being tested in trial NCT07425015?
The interventions under investigation include: Glean Urodynamics System (DEVICE).
Who is sponsoring clinical trial NCT07425015?
This trial is sponsored by Bright Uro, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07425015 being conducted?
This trial has 7 study locations across Maryland, Missouri, Ohio, South Carolina, South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Benign Prostatic Hyperplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07425015's enrollment target sits among peer trials
101 20th of 29 higher than 10 of 29 other Benign Prostatic Hyperplasia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Benign Prostatic Hyperplasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
RECRUITING · NA
-
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RECRUITING · NA
-
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
RECRUITING · NA
-
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
RECRUITING · NA
-
PRescription Exercise for Older Men With Urinary Disease
RECRUITING · NA
-
Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia